|
Hallo Hohenlohe. I`ve held PSD since 2001, and increased my shareholding over that time. I`m an investor, not a trader. Yes, I think it`s a good opportunity, but still a risk. It all depends on how well Brachysil does and how much the large pharmceutical companies take up Biosilicon drug delivery. There`s no way at this stage to predict how well those will go, but I`m prepared to take the chance on it. It seems that I spoke too soon about the sell-off. Today has started very badly on the ASX with more selling (437,00 volume and 0,67 price as I write). Well, I still expect it to recover, but I can`t say when. Pezz P.S. I use Google to translate the messages here to English, so I do have some idea of what the German messages are saying. |
|
| aus der Diskussion: | EyePoint Pharmaceuticals (vorher: PSIVIDA) startet durch !! |
| Autor (Datum des Eintrages): | Pezzimist (24.11.05 00:41:53) |
| Beitrag: | 3,521 von 12,859 (ID:18960285) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |